DK638389A - Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne - Google Patents

Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne Download PDF

Info

Publication number
DK638389A
DK638389A DK638389A DK638389A DK638389A DK 638389 A DK638389 A DK 638389A DK 638389 A DK638389 A DK 638389A DK 638389 A DK638389 A DK 638389A DK 638389 A DK638389 A DK 638389A
Authority
DK
Denmark
Prior art keywords
echariotic
beta2
precautions
codes
procedures
Prior art date
Application number
DK638389A
Other languages
Danish (da)
English (en)
Other versions
DK638389D0 (da
Inventor
Anthony F Purchio
Linda Madisen
Nancy Webb
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of DK638389D0 publication Critical patent/DK638389D0/da
Publication of DK638389A publication Critical patent/DK638389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK638389A 1988-12-16 1989-12-15 Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne DK638389A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28514088A 1988-12-16 1988-12-16
US07/446,020 US5221620A (en) 1987-10-06 1989-12-05 Cloning and expression of transforming growth factor β2

Publications (2)

Publication Number Publication Date
DK638389D0 DK638389D0 (da) 1989-12-15
DK638389A true DK638389A (da) 1990-06-17

Family

ID=26963007

Family Applications (1)

Application Number Title Priority Date Filing Date
DK638389A DK638389A (da) 1988-12-16 1989-12-15 Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne

Country Status (8)

Country Link
US (1) US5221620A (de)
EP (2) EP0376785A3 (de)
CN (1) CN1045992A (de)
AU (1) AU640115B2 (de)
DK (1) DK638389A (de)
FI (1) FI896001A7 (de)
IL (1) IL92737A0 (de)
NZ (1) NZ231803A (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0502036B1 (de) * 1989-11-22 1995-12-20 Genentech, Inc. Latenz assoziierte peptide und deren verwendung
US5168050A (en) * 1990-05-24 1992-12-01 Genentech, Inc. Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors
IT1259042B (it) * 1992-01-27 1996-03-11 Mini Ricerca Scient Tecnolog Preparazione di vettori di espressione per la sintesi del polipeptide chiamato fattore osteogenetico op-1 in cellule eucariotiche di spodoptera frugiperda via infezione con baculovirus ricombinante
DK0625989T3 (da) * 1992-02-12 2000-06-26 Bioph Biotech Entw Pharm Gmbh DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5847007A (en) * 1993-05-13 1998-12-08 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6455689B1 (en) * 1993-04-30 2002-09-24 Biognostik Gesellschaft für Biomolekulare Diagnostik mbH Antisense-oligonucleotides for transforming growth factor-β (TGF-β)
US5994102A (en) * 1994-12-15 1999-11-30 Human Genome Sciences, Inc. Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US6521227B1 (en) 1999-11-18 2003-02-18 Peter L. Hudson Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
CA2223595C (en) 1995-06-07 2008-08-05 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
EP0856579A1 (de) * 1997-01-31 1998-08-05 BIOGNOSTIK GESELLSCHAFT FÜR BIOMOLEKULARE DIAGNOSTIK mbH Ein Verfahren zur Zubereitung von Antisense Oligonukleotiden
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
CA2345024C (en) * 1998-10-07 2009-05-19 Stryker Corporation Modified tgf-.beta. superfamily proteins
US6756215B1 (en) * 2000-10-20 2004-06-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Functionalized TGF-β fusion proteins
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
EP1740609A2 (de) 2004-04-27 2007-01-10 Research Development Foundation Antagonismus des tgf-beta superfamily signal rezeptors
CN100389120C (zh) * 2005-04-12 2008-05-21 中国人民解放军第三军医大学野战外科研究所 封闭TGF－β1的反义寡核苷酸及其在制备治疗纤维化相关疾病药物中的用途
WO2010144696A1 (en) 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
DE3382562D1 (de) * 1982-09-24 1992-06-25 Us Health Wiederherstellung von gewebe bei tieren.
WO1984004924A1 (en) * 1983-06-03 1984-12-20 Us Commerce Purified transforming growth factor-beta derived from human platelets and placentas
CA1341401C (en) * 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
EP0155433A1 (de) * 1984-03-23 1985-09-25 Adriano Fontana Immunsuppressionsfaktor
US4708948A (en) * 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
EP0169016B2 (de) * 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Knorpel-induzierende Polypeptid-Faktoren aus Knochen
IL78197A (en) * 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
PT86144B (pt) * 1986-11-17 1990-08-31 Sandoz Sa Processo para a preparacao de uma proteina tendo actividade semelhante a factor g-tsf humano e de composicoes farmaceuticas que o contem
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
EP0293785A3 (de) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
AU630075B2 (en) * 1987-10-06 1992-10-22 Bristol-Myers Squibb Company Cloning and expression of transforming growth factor 2b
IL87877A0 (en) * 1987-10-06 1989-03-31 Oncogen Cloning and expression of transforming growth factor beta2

Also Published As

Publication number Publication date
EP0376785A3 (de) 1992-01-02
AU4683589A (en) 1991-06-21
CN1045992A (zh) 1990-10-10
AU640115B2 (en) 1993-08-19
EP0376785A2 (de) 1990-07-04
FI896001A0 (fi) 1989-12-14
US5221620A (en) 1993-06-22
IL92737A0 (en) 1990-09-17
DK638389D0 (da) 1989-12-15
EP0676474A1 (de) 1995-10-11
FI896001A7 (fi) 1990-06-17
NZ231803A (en) 1992-10-28

Similar Documents

Publication Publication Date Title
DK638389D0 (da) Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne
DK464087A (da) Haloarylnitril-nedbrydende gen, anvendelsen heraf og celler indeholdende dette
DK120188A (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK316189D0 (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
GR3017451T3 (en) Peptides having T cell helper activity.
NO871165L (no) 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler inneholdende dem og deres anvendelse.
DK650489A (da) Transgene organismer og celler samt fremgangsmaader til fremstilling deraf
NO871167D0 (no) 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler som inneholder disse og deres anvendelse.
DE3782733D1 (de) Sonnenzellensystem.
DK4387A (da) Human-praepo-insulinlignende-vaekstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne
DK388789D0 (da) Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
NO863765D0 (no) Arylmetylazoler og salter derav samt fremgangsmaater til fremstilling derav.
NO875263L (no) 2,3-disubstituerte isoksazolidiner, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse.
NO165639C (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK675387A (da) Substituerede phenoxypyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider og plantevaekstregulerende midler
DK127188A (da) L-arylpyrazoler, fremgangsmaade til deres fremstilling samt deres anvendelse som herbicider og plantevaekstregulerende midler
DK178589D0 (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
NO871166L (no) 2-azolylmetyl-2-aryl-1,3-dioksolaner og deres salter, fremgangsmaate til deres fremstilling, midler som inneholder dem og deres anvendelse.
DK231089D0 (da) Substituerede azolthioethere, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel
DK279587D0 (da) Fremgangsmaade til fremstilling af mikrobaerere for dyrkning af celler, og mikrobaerere fremstillet ved denne fremgangsmaade
DK264688D0 (da) Annelerede (thio)hydantoiner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
AU7362287A (en) Whole cell vaccines comprising cells having had dna destroyed
DK570388D0 (da) Pyridylphosphater, fremgangsmaade til deres fremstilling samt deres anvendelse som pesticider
DK321387D0 (da) Cytorhodin s-derivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment